FAILURE OF HYPOMETHYLATING AGENT-BASED THERAPY IN MYELODYSPLASTIC SYNDROMES

Lignende værker

• Acute Myeloid Leukemia Following Myelodysplastic Syndrome and Failure of Therapy with Hypomethylating Agents: An Emerging Entity With a Poor Prognosis
  af: Jabbour, Elias, et al.
  Udgivet: (2013)
• Clinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agents
  af: Takahashi, Koichi, et al.
  Udgivet: (2016)
• Beyond hypomethylating agents failure in patients with myelodysplastic syndromes
  af: Zeidan, Amer M., et al.
  Udgivet: (2014)
• The efficacy of current prognostic models in predicting outcome of patients with myelodysplastic syndromes at the time of hypomethylating agent failure
  af: Nazha, Aziz, et al.
  Udgivet: (2016)
• Impact of Achievement of Complete Cytogenetic Response on Outcome in Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agents
  af: Jabbour, Elias, et al.
  Udgivet: (2017)